cancer |
aflibercept |
As nouns the difference between cancer and aflibercept
is that
cancer is cancer while
aflibercept is a fusion protein under development for the treatment of cancer.
antiphosphatidylserine |
bavituxumab |
As a noun bavituxumab is
a chimeric antiphosphatidylserine monoclonal antibody analogue with possible applications in treating cancers and viral infections.
analogue |
bavituxumab |
As nouns the difference between analogue and bavituxumab
is that
analogue is (british|canadian) while
bavituxumab is a chimeric antiphosphatidylserine monoclonal antibody analogue with possible applications in treating cancers and viral infections.
As an adjective analogue
is (british|canadian).
cancer |
bavituxumab |
As nouns the difference between cancer and bavituxumab
is that
cancer is a disease in which the cells of a tissue undergo uncontrolled (and often rapid) proliferation while
bavituxumab is a chimeric antiphosphatidylserine monoclonal antibody analogue with possible applications in treating cancers and viral infections.
As a proper noun Cancer
is a constellation of the zodiac supposedly shaped like a crab.
viral |
bavituxumab |
As nouns the difference between viral and bavituxumab
is that
viral is (marketing) a video, image or text spread by "word of mouth" on the internet or by e-mail for humorous, political or marketing purposes while
bavituxumab is a chimeric antiphosphatidylserine monoclonal antibody analogue with possible applications in treating cancers and viral infections.
As an adjective viral
is (virology) of or relating to a biological virus.
infection |
bavituxumab |
As nouns the difference between infection and bavituxumab
is that
infection is (pathology) the act or process of infecting while
bavituxumab is a chimeric antiphosphatidylserine monoclonal antibody analogue with possible applications in treating cancers and viral infections.
cancer |
apolizumab |
As nouns the difference between cancer and apolizumab
is that
cancer is cancer while
apolizumab is a humanized monoclonal antibody being studied as a treatment for hematologic cancers.
immunosuppressive |
aselizumab |
As nouns the difference between immunosuppressive and aselizumab
is that
immunosuppressive is (pharmacology) an agent which is capable of immunosuppression while
aselizumab is a particular immunosuppressive drug.
As an adjective immunosuppressive
is (pharmacology) having the capability to suppress the immune system, capable of immunosuppression.
drug |
aselizumab |
As nouns the difference between drug and aselizumab
is that
drug is a substance used to treat an illness, relieve a symptom, or modify a chemical process in the body for a specific purpose while
aselizumab is a particular immunosuppressive drug.
As a verb drug
is to administer intoxicating drugs to, generally without the recipient's knowledge or consent.
lymphoma |
afutuzumab |
As nouns the difference between lymphoma and afutuzumab
is that
lymphoma is (oncology|pathology) a malignant tumor that arises in the lymph nodes or in other lymphoid tissue while
afutuzumab is a monoclonal antibody used to treat lymphoma.
Pages